본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Update on treatments for anxiety-related disorders
()

Lee Hyun Jeong
(Division of Cancer Management Policy)
. Update on treatments for anxiety-related disorders. CURRENT OPINION IN PSYCHIATRY. 2022-12-07; 2022; Online:Published. IF 4.787 (2021)
Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing Rag1 Knock-Out Mice Han Chung Yong
(Immuno-oncology Branch)

Kim Seon Hee
(Immuno-oncology Branch)
. Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing Rag1 Knock-Out Mice. CELLS. 2022-12-02; 2022; 11(23):3894~. IF 7.666 (2021)
Post-Translational Modification of ZEB Family Members in Cancer Progression Park Mi Kyung
(Department of Cancer Biomedical Science)

Park Mi Kyung
(Department of Cancer Biomedical Science)
. Post-Translational Modification of ZEB Family Members in Cancer Progression. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022-12-01; 2022; 23(23):15127~. IF 6.208 (2021)
An update on biologic treatments for neuromyelitis optica spectrum disorder Kim Ho Jin
(Division of Rare and Refractory Cancer )


()
. An update on biologic treatments for neuromyelitis optica spectrum disorder. EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 2022-11-30; 2022; 19(1):111~121. IF 5.124 (2021)
Risk stratification of nonmuscle invasive bladder cancer and innovative approaches to management of Ta low grade tumors
()

Kim Sung Han
(Immuno-oncology Branch)
. Risk stratification of nonmuscle invasive bladder cancer and innovative approaches to management of Ta low grade tumors. JOURNAL OF CLINICAL ONCOLOGY. 2022-11-30; 2022; Online:Published. IF 50.739 (2021)
A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non?small cell lung cancer with EGFR mutation Han Ji-Youn
(Anticancer Resistance Branch )

Lee Young Joo
(Targeted Therapy Branch)
. A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non?small cell lung cancer with EGFR mutation. CANCER. 2022-11-30; 2022; Online:Published. IF 6.921 (2021)
Interobserver Variability Prediction of Primary Gross Tumor in a Patient with Non-Small Cell Lung Cancer Kim Haksoo
(Department of Radiation oncology)

Cheon Won Joong
(Center for Proton Therapy)
. Interobserver Variability Prediction of Primary Gross Tumor in a Patient with Non-Small Cell Lung Cancer. CANCERS. 2022-11-29; 2022; 14(23):5893~. IF 6.575 (2021)
Multimorbidity patterns by health-related quality of life status in older adults: An association rules and network analysis utilizing Korean National Health and Nutrition Examination Survey Cho, Hyunsoon
(Department of Cancer AI and Digital Health)

Tran Thi Ngoc
(Department of Cancer Control and Population Health)
. Multimorbidity patterns by health-related quality of life status in older adults: An association rules and network analysis utilizing Korean National Health and Nutrition Examination Survey. EPIDEMIOLOGY AND HEALTH. 2022-11-29; 2022; Online:Published. IF 5.919 (2021)
Avoiding a Collision in Gamma Knife Radiosurgery : A Modified Mask Fixation Method Dho Yun Sik
(Department of Neurosurgery)


()
. Avoiding a Collision in Gamma Knife Radiosurgery : A Modified Mask Fixation Method. JOURNAL OF KOREAN NEUROSURGICAL SOCIETY. 2022-11-28; 2022; 66(4):476~481. IF 2.249 (2021)
Effects of Diabetes Quality Assessment on Diabetes Management Behaviors Based on a Nationwide Survey
()

Choi Chang Kyun
(Division of Cancer Screening and Early Detection)
. Effects of Diabetes Quality Assessment on Diabetes Management Behaviors Based on a Nationwide Survey. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2022-11-27; 2022; :~. IF 4.614 (2021)